Boost Disclosures by Utilizing Proven Technology Scouting Methods
Originally presented March 28, 2011
Historically, technology "scouting" has been utilized in the private sector to mine university innovations and secure valuable research for the corporate pipeline. This approach continues to be successful and profitable — so much so that a growing number of tech transfer offices are incorporating some of the same scouting strategies into their own procedures.
One technology transfer program stands out from the crowd – Emory University's VentureLab. Led by visionary Kevin Lei, and employing the technology scouting methods revealed in this program, the VentureLab has increased its disclosure rate in every year of its existence. In fact, the program's raw number of annual disclosures nearly doubled to 212 over a six-year period, with an average year-to-year increase of 15%.
Join Kevin and the architect of the scouting strategy, Emory tech transfer director Todd Sherer for this practical, program that's jam-packed with specific strategies and takeaways:
Boost Disclosures by Utilizing
Proven Technology Scouting Methods
Here's a brief look at what they will cover:
Your Expert Panel of Presenters:
Todd Sherer, PhD, is Associate Vice President for Research Administration and Director of Technology Transfer at Emory University in Atlanta, Georgia. He leads a team of 20 focused on creating value from intellectual property developed by Emory researchers. Since joining Emory in 2003, Todd has expanded the program by twelve staff, instituted a commercially oriented product pipeline to highlight Emory's varied portfolio, and created an in-house patent department to reduce costs and better align patent work with research activity. His new initiatives have transformed the office's focus from one of transactional support to one of value creation. Licensing revenues have exceeded $650 million since Todd joined the office. He also worked with colleagues to monetize downstream licensing revenues on an Emory-discovered molecule that is now part of the leading AIDS drug cocktail — resulting in a $540 million, one-time payment from the licensee, Gilead Sciences. Before joining Emory, Todd was Director of Technology and Research Collaborations at Oregon Health & Science University in Portland. At the University of Oregon in Eugene, he was Director of the Office of Technology Transfer. In addition, Todd is the incoming President-Elect for the Association of University Technology Managers (AUTM) and serves on the Board of Directors of Southeast BIO (SEBIO). He is a Registered Patent Agent with the USPTO and a Certified Licensing Professional.
Kevin Lei is Associate Director in the Emory University Office of Technology Transfer and Director of the VentureLab Program. He previously held positions as licensing associate, senior licensing associate, and assistant director within the office. His current responsibilities include faculty start-up development, technology scouting, and translational research support. Kevin's 24-year prior employment history has included positions in both academic and industrial sectors. Seventeen of those years have been spent in positions of increasing responsibility within the medical industry and life sciences technology transfer. Kevin was a bench scientist, an operations manager of a biotech incubator, a founding president of a biotech start-up, and an R&D manager for a Georgia-based biotech company before joining Emory fourteen years ago. Kevin is a Certified Licensing Professional.